Has David Sabir, MD received payments from drug or device companies?

Yes. Drug and device makers reported $254 in general payments to David Sabir, MD across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Sabir, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Sabir, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Sabir, MD

Ophthalmology · Brainerd, MNNPI 1942293949

Payments from drug & device makers

$254in general payments, 2019–2025

Across 12 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Glaukos Corporation$97
Apellis Pharmaceuticals, Inc.$76
Alcon$33
Oyster Point Pharma, Inc.$27
Regeneron Healthcare Solutions, Inc.$21

What the payments were for

Food & beverage$254100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Glaukos Corporation	3	$97
Apellis Pharmaceuticals, Inc.	4	$76
Alcon	2	$33
Oyster Point Pharma, Inc.	2	$27
Regeneron Healthcare Solutions, Inc.	1	$21

How this compares

$254 in reported general payments places this provider in the 45th percentile of 330 ophthalmology providers in Minnesota.

See all ophthalmology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$326,234

Medicare patients

703

Services billed

2,480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RestasisCyclosporine	14	$15,171
Prednisolone Acetate	343	$11,480
Restasis MultidoseCyclosporine	14	$9,153
Latanoprost	411	$5,584
LumiganBimatoprost	15	$4,578
Ketorolac Tromethamine	249	$3,881
Ofloxacin	253	$3,255
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	224	$2,981
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	118	$2,416
Timolol Maleate	103	$1,928
Brimonidine Tartrate	31	$1,921
Mycophenolate Mofetil	12	$345
ErythromycinErythromycin Base	29	$283
ValacyclovirValacyclovir Hcl	17	$201
Acetazolamide ErAcetazolamide	13	$176

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Brainerd

Edwin RyanMinneapolis$9.6M
Richard LindstromBloomington$9M
Mark LobanoffSt Louis Park$7M
Robert MittraMinneapolis$5.1M
David ParkeMinneapolis$4.5M
Yun-Sen ChuBloomington$1.7M
Deborah RistvedtAlexandria$1.3M
John DaviesMinneapolis$1.3M
Sundeep DevMinneapolis$673K
Jeffrey FischerWillmar$507K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →